Miocamycin
Miocamycin (Midecamycin acetate) is a derivative of midecamycin , a macrolide antibiotic that can be isolated from a culture broth of Streptomyces mycarofaciens. Miocamycin has antibacterial properties[1].
Product Specifications
CAS Number
55881-07-7
Product Name Alternative
Midecamycin acetate; Ponsinomycin
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/miocamycin.html
Solubility
10 mM in DMSO
Smiles
CO[C@@H]([C@@H](CC(O[C@@H](C/C=C/C=C/[C@@H]([C@@H](C[C@@H]1CC=O)C)OC(C)=O)C)=O)OC(CC)=O)[C@H]1O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@](C)([C@H]([C@@H](O3)C)OC(CC)=O)OC(C)=O)N(C)C)O
Molecular Formula
C45H71NO17
Molecular Weight
898.04
References & Citations
[1]TOXICOLOGICAL STUDIES ON A NEW MACROLIDE ANTIBIOTIC, MIDECAMYCIN ACETATE (MIOCAMYCIN) . July 1984. Volume 37 Issue 7 Pages 1355-1375.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K7234206 1.0 µg DNA
Rab24 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details